(85 days)
No
The summary describes a mechanical catheter delivery system and its components. There is no mention of AI, ML, or any software-driven analytical capabilities. The changes described are purely physical modifications to the device components.
No
The device is a delivery system for therapeutic devices; it does not directly perform a therapeutic function itself.
No
The device is a delivery system for introducing other transvenous devices, which may include diagnostic devices, but the delivery system itself is not described as performing any diagnostic function. Its indication is to "provide a pathway".
No
The device description explicitly lists multiple hardware components (needle, syringe, guide wire, valve, deflectable catheter, dilator, slitter) and describes physical changes to these components. There is no mention of software as a component or function of the device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly states that the device is used to "provide a pathway through which diagnostic and therapeutic transvenous devices are introduced within the chambers and coronary vasculature of the heart." This describes a device used in vivo (within a living organism) for delivering other devices.
- Device Description: The description details components like needles, guide wires, catheters, and dilators, all of which are used for accessing and navigating within the body.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens (like blood, tissue, or urine) in vitro (outside of the body) to provide information about a physiological state, health, or disease.
IVD devices are specifically designed for testing biological samples outside of the body. This device is designed for direct use within the patient's circulatory system.
N/A
Intended Use / Indications for Use
The deflectable catheter delivery system is indicated to provide a pathway through which diagnostic and therapeutic transvenous devices are introduced within the chambers and coronary vasculature of the heart, and for introducing balloon catheters into the coronary sinus or leads into vessels of the left heart via the coronary sinus.
Product codes
DOY, 74 DQY
Device Description
The 6226DEF system features a percutaneous needle and syringe to access the venous insertion site, a guide wire to access the vein, a valve to reduce blood loss during the implant procedure, a deflectable catheter to introduce a transvenous device, a deflectable catheter dilator to facilitate deflectable catheter passage, and a slitter to remove the deflectable catheter.
The Attain 6226DEF Deflectable Catheter Delivery System combines devices that are either pre-amendment devices, devices that are cleared for market distribution via 510(k), or are exempt from premarket notification because of Class I designation.
The key changes being made to the system versus the predicate 10600 device are a decrease in the length of the deflectable catheter, a reduction in the stiffness of the deflectable catheter tip, and a change in the articulated shape of the catheter. The dilator length is also decreased in line with the catheter. In addition the slitters are replaced by a Universal Slitter and the adjustable hemostasis valve is replaced by an introducer valve. The entire system is packaged in a revised packaging configuration.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
chambers and coronary vasculature of the heart, coronary sinus, vessels of the left heart via the coronary sinus
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
In vitro testing and biocompatibility/sterilization testing was performed to support substantial equivalence to the predicate device. The results of this testing indicates that the Attain 6226DEF meets all of its design and performance requirements.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.1250 Percutaneous catheter.
(a)
Identification. A percutaneous catheter is a device that is introduced into a vein or artery through the skin using a dilator and a sheath (introducer) or guide wire.(b)
Classification. Class II (performance standards).
0
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/0/Picture/1 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular and contains the department's logo, which features three stylized human profiles facing right. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged around the perimeter of the circle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
2003 NOV 3
Medtronic, Inc. c/o Ms. Kristina Mollner Sr. Regulatory Affairs Specialist Cardiac Rhythm Management 7000 Central Avenue, NE Minneapolis, MN 55432
Re: K032312
Trade Name: ATTAIN™ 6226DEF Deflectable Catheter Delivery System Regulation Number: 21 CFR 870.1250 Regulation Name: Percutaneous Catheter Regulatory Class: Class II (two) Product Code: DOY Dated: September 19, 2003 Received: September 22, 2003
Dear Ms. Mollner:
This letter corrects our substantially equivalent letter of October 21, 2003 regarding the designation as class III (three) in the letter. The correct class for the device is class II (two).
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. However, you are responsible to determine that the medical devices you use as components in the [kit/tray] have either been determined as substantially equivalent under the premarket notification process (Section 510(k) of the act), or were legally on the market prior to May 28, 1976, the enactment date of the Medical Device Amendments. Please note: If you purchase your device components in bulk (i.e., unfinished) and further process (e.g., sterilize) you must submit a new 510(k) before including these components in your kit/tray. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, and labeling, and prohibitions against misbranding and adulteration.
1
Page 2 - Ms. Kristina Mollner
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration (21 CFR Part 807); listing (21 CFR Part 807), labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on the labeling regulation, please contact the Office of Compliance at (301) 594-4646. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll free number (800) 638-2041 or (301) 443-6597, or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html.
Sincerely yours,
O. Malla
Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
OCT 2 1 2003
510(K) Summary of Substantial Equivalence
| Date prepared | 25 July, 2003 |
|---|---|
| Submitter: | Medtronic Ireland |
| Parkmore Business Park West | |
| Galway | |
| Ireland | |
| Submission Correspondent: | Kristina Mollner |
| Sr. Regulatory Affairs Specialist | |
| 7000 Central Avenue, N.E. | |
| Minneapolis, MN 55432 | |
| Telephone: | (763) 514-3914 |
| Fax: | (763) 514-6424 |
| E-Mail: | kristina.mollner@medtronic.com |
| Proprietary Name: | Attain™ 6226DEF Deflectable Catheter Delivery |
| System | |
| Common Name: | Catheter, Percutaneous |
| Device Classification: | Class II, 21 CFR § 870.1250 |
| Product Code: | 74 DQY |
Performance Standard
Performance standards do not currently exist for these devices. None established under Section 514.
3
Device Description
The 6226DEF system features a percutaneous needle and syringe to access the venous insertion site, a guide wire to access the vein, a valve to reduce blood loss during the implant procedure, a deflectable catheter to introduce a transvenous device, a deflectable catheter dilator to facilitate deflectable catheter passage, and a slitter to remove the deflectable catheter.
The Attain 6226DEF Deflectable Catheter Delivery System combines devices that are either pre-amendment devices, devices that are cleared for market distribution via 510(k), or are exempt from premarket notification because of Class I designation.
The key changes being made to the system versus the predicate 10600 device are a decrease in the length of the deflectable catheter, a reduction in the stiffness of the deflectable catheter tip, and a change in the articulated shape of the catheter. The dilator length is also decreased in line with the catheter. In addition the slitters are replaced by a Universal Slitter and the adjustable hemostasis valve is replaced by an introducer valve. The entire system is packaged in a revised packaging configuration.
Indications for Use
The deflectable catheter delivery system is indicated to provide a pathway through which diagnostic and therapeutic transvenous devices are introduced within the chambers and coronary vasculature of the heart, and for introducing balloon catheters into the coronary sinus or leads into vessels of the left heart via the coronary sinus.
4
Substantially Equivalent Devices
Attain 6226DEF Deflectable catheter delivery system predicate devices
The design, technology, features, functions and intended use of the 6226DEF Deflectable Catheter Delivery System are substantially equivalent to the following predicate devices currently in interstate commerce.
| Attain 6226DEF
Deflectable
Catheter Delivery
System | Predicate Device | Predicate Device
Manufacturer | Predicate 510(k) |
|--------------------------------------------------------------|------------------------------------------------|-------------------------------------------------------|----------------------------------------------------------|
| Deflectable
catheter | Medtronic 10600
Deflectable catheter system | Medtronic, Inc.
Minneapolis, MN 55432 | K013517 |
| Guide Catheter
Dilator | Medtronic 10600
Deflectable catheter system | Medtronic, Inc.
Minneapolis, MN 55432 | K013517 |
| Guide Wire | Medtronic 10600
Deflectable catheter system | Medtronic, Inc.
Minneapolis, MN 55432 | K013517 |
| Introducer valve | Cook 6228VAL Introducer
Valve | Cook Vascular Incorporated
Leechburg, PA 15656 USA | K010128 |
| Universal Slitter | Medtronic 6228SLT
Universal Slitter | Medtronic, Inc.
Minneapolis, MN 55432 | Class I device, exempt
from premarket
notification |
| Needle | Medtronic 10600
Deflectable catheter system | Medtronic, Inc.
Minneapolis, MN 55432 | K013517 |
| Syringe | Medtronic 10600
Deflectable catheter system | Medtronic, Inc.
Minneapolis, MN 55432 | K013517 |
Additionally, the biocompatibility of the Attain 6226DEF Deflectable Catheter Delivery System is substantially equivalent to the following device.
| Attain 6226DEF
Deflectable
Catheter Delivery
System | Predicate Device | Predicate Device
Manufacturer | Predicate 510(k) |
|--------------------------------------------------------------|---------------------------------------------------------------|------------------------------------------|------------------|
| Deflectable
catheter | Medtronic Attain Access
6218 Left-Heart Delivery
System | Medtronic, Inc.
Minneapolis, MN 55432 | K012083 |
5
CONFIDENTIAL
May not be reproduced without written permission from Medtronic, Inc.
Summary of Studies
In vitro testing and biocompatibility/sterilization testing was performed to support substantial equivalence to the predicate device. The results of this testing indicates that the Attain 6226DEF meets all of its design and performance requirements.
Biocompatibility Information
Materials/components of the Attain 6226DEF kit were evaluated for compliance to ISO10993. All materials were found to be biocompatible and in compliance to ISO10993.
Sterilization Validation
The Attain 6226DEF Deflectable catheter delivery system is sterilized using a 100% Ethylene Oxide (ETO) sterilization process. Appropriate processes for sterilizing the devices were validated.
Conclusion (Statement of Equivalence)
Through the data and information presented, as well as similarities to legally marketed devices, Medtronic, Inc. considers the Attain 6226DEF deflectable catheter delivery system to be substantially equivalent to the previously discussed legally marketed predicate devices.
6
CONFIDENTIAL May not be reproduced without written permission from Medtronic, Inc.
Indications for Use Statement
| 510(k) Number (if known): | N/A |
|---|---|
| Device Name: | Attain™ 6226DEF Deflectable catheter delivery system |
| Indications For Use: | The deflectable catheter delivery system is indicated to provide a pathway through which diagnostic and therapeutic transvenous devices are introduced within the chambers and coronary vasculature of the heart, and for introducing balloon catheters into the coronary sinus or leads into vessels of the left heart via the coronary sinus. |
PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED
Concurrence of CDRH, Office of Device Evaluation (ODE)
| Prescription Use
| (Per 21 CFR 801.109) | X |
|---|---|
| ------------------------------------------ | --- |
OR
| (Division Sign-Off) | |
|---|---|
| Division of Cardiovascular Devices |
| Over-The-Counter Use | |
|---|---|
| ---------------------- | -- |
| 510(k) Number | K032312 |
|---|---|
| --------------- | --------- |
Special 510(k): Device Modification Premarket Notification Attain™ 6226DEF Deflectable Catheter Delivery System